Amkor reported third-quarter 2026 results on October 26, 2026. Net sales were $1.99 billion, roughly flat from a year earlier and up from $1.90 billion in the second quarter, while diluted EPS rose to $0.76 from $0.51. The company guided fourth-quarter diluted EPS to $0.65 to $0.75 and updated full-year 2026 capital expenditures to about $2.5 billion.
Q3 2026 net income attributable to Amkor was $191 million, versus $127 million in Q3 2025
Gross margin was 18.3%, up from 14.3% a year earlier; operating income was $225 million
Q4 2026 guidance: net sales of $1.9 billion to $2.0 billion and net income of $160 million to $185 million
Full-year 2026 capital expenditures were updated to approximately $2.5 billion
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Amkor Technology's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$6.71B
+6.2%
$1.50
+4.9%
5.6%
FY2024
$6.32B
-2.9%
$1.43
-2.1%
5.6%
FY2023
$6.50B
-8.3%
$1.46
-53.1%
5.5%
FY2022
$7.09B
+15.5%
$3.11
+18.7%
10.8%
FY2021
$6.14B
+21.5%
$2.62
+87.1%
10.5%
Frequently asked questions
When is Amkor Technology's next earnings date?
Amkor Technology has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did Amkor Technology earn last quarter?
For the quarter ended Sep 2026, Amkor Technology reported diluted EPS of $0.76 (+49.0% year over year) on revenue of $1.99B (+0.2%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.